Net Income (Loss) Attributable to Parent in USD of TriSalus Life Sciences, Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
TriSalus Life Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2020 to Q3 2025.
  • TriSalus Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$10.8M, a 351% decline year-over-year.
  • TriSalus Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$39.6M, a 28.8% increase year-over-year.
  • TriSalus Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$30M, a 49.4% increase from 2023.
  • TriSalus Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$59.4M, a 25.8% decline from 2022.
  • TriSalus Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$47.2M, a 1090% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

TriSalus Life Sciences, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$39.6M -$10.8M -$8.41M -351% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 -$31.2M -$8.29M -$3.96M -91.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-13
Q1 2025 -$27.2M -$10.4M +$2.83M +21.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-13
Q4 2024 -$30M -$10.1M +$25.5M +71.6% Oct 1, 2024 Dec 31, 2024 10-K/A 2025-05-30
Q3 2024 -$55.6M -$2.4M -$974K -68.4% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 -$54.6M -$4.33M +$9.65M +69% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-13
Q1 2024 -$64.3M -$13.2M -$4.89M -58.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-13
Q4 2023 -$59.4M -$35.6M -$13.1M -58.1% Oct 1, 2023 Dec 31, 2023 10-K/A 2025-05-30
Q3 2023 -$46.3M -$1.43M +$6.67M +82.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$52.9M -$14M -$5.31M -61.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$47.6M -$8.31M -$440K -5.59% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$47.2M -$22.5M -$25.4M -878% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-11
Q3 2022 -$21.7M -$8.09M -$9.96M -534% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$11.8M -$8.68M -$9.06M -2391% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$2.73M -$7.87M -$7.5M -2016% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 $4.77M $2.9M +$3.61M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $1.16M $1.86M +$1.87M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$706K $379K Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$372K Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$711K Sep 11, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$1K* Sep 11, 2020 Sep 30, 2020 10-Q/A 2021-12-13

TriSalus Life Sciences, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$30M +$29.3M +49.4% Jan 1, 2024 Dec 31, 2024 10-K/A 2025-05-30
2023 -$59.4M -$12.2M -25.8% Jan 1, 2023 Dec 31, 2023 10-K/A 2025-05-30
2022 -$47.2M -$52M -1090% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-11
2021 $4.77M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.